Drug · DIN 02569604
EDARAVONE
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since June 26, 2026.
- Drug Identification Number (DIN)
- 02569604
- Company (DIN owner)
- Shionogi Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Suspension
- Route
- Oral
- Therapeutic class (ATC)
- Edaravone N07XX14
- Class
- Human
- Record last updated
- June 30, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EDARAVONE | 105 MG | 5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 26, 2026: NOC 37783New Drug Submission (NDS) · Administrative: Licensing Agreement between two manufacturers